jetcityimage/iStock Editorial through Getty Photographs
UnitedHealth Group (NYSE:UNH) is intensifying its lobbying push in Washington because it faces prison and civil investigations into its Medicare Benefit enterprise and grapples with modifications to federal cost guidelines which have pressured earnings, The Wall Road Journal reported Sunday.
